Epidermolysis Bullosa Completed Phase 2 Trials for Allantoin (DB11100)

Also known as: EPIDERMOLYSIS BULLOSA / Koebner's disease

IndicationStatusPhase
DBCOND0028939 (Epidermolysis Bullosa)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00825565Study of Alwextin® Cream in Treating Epidermolysis BullosaTreatment